Let’s be ‘Corona Clever’ and Catch one Before the POP. Athersys (ATHX) $1.85
It's a bit of a stretch...
Okay, it's a bit of a stretch,...
Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!
Great headline, right?
The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million
Corona Craziness Continues. Immuron (IMRN) Gains 10-Fold or 1000%, in 3 Months!
Too bad we don’t trade for a living! We don’t even use real-time quotes, LOL. $2.57 to $27.13, from March 3rd ...
Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement for DermAphex® and...
PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization solutions company focused on the development and distribution...
Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).
Clorox shares have soared more than 54% for the year to date, an increase of $11.5 billion to $29.5 billion.
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
